This protocol addresses extrapapillary retinal hemangioblastomas in the 1.5 to 4.5 mm diameter range — a size category that presents specific challenges for laser-based management and requires a carefully tailored approach.
Extrapapillary retinal hemangioblastomas in this size range are more difficult to destroy using thermal laser photocoagulation compared with smaller lesions. Treatment typically requires multiple sessions and deliberate parameter adjustments to achieve adequate tumor destruction.
The protocol centers on thermal laser photocoagulation directed at the tumor, with burn parameters specifically calibrated for this tumor size. When the treated tumor poses a meaningful risk of post-treatment exudation, a short adjunctive course of systemic corticosteroids may be incorporated. The complete sequencing, session planning, and management details are available in the full protocol.
Extrapapillary RH between 1.5 and 4.5 mm in diameter are more difficult to destroy using thermal laser photocoagulation.
Direct treatment of the tumor typically involves application of long-duration burns (usually 0.4 to 0.7 seconds) using a power setting lower than that needed for a typical panretinal photocoagulation or laser retinopexy spot, with a goal of maximizing penetration over the course of the burn.
Those of us who use this approach tailor the steroid dose to the anticipated risk of exudation, typically giving prednisone up to 1 mg/kg/day (or equivalent) for one to three days, beginning on the day of treatment, with rapid taper to discontinuation within four to seven days after treatment.
Encouraging signs include a decrease in tumor size, decrease in redness or vascularity, resolution of any subretinal fluid and hard exudation, normalization of the caliber and decrease in the tortuosity of any feeder vessels, and an underlying chorioretinal scar.
View source ↗